US HOT NEWS Logo
US HOT NEWS
US Markets
DJIA43,842.10+168.45 (+0.39%)
SPX5,864.67+24.80 (+0.42%)
COMP18,518.61+102.32 (+0.56%)
TNX4.18%-0.04 (-0.95%)
CL$71.25-0.82 (-1.14%)
GC$2,674.30+14.60 (+0.55%)
DJIA43,842.10+168.45 (+0.39%)
SPX5,864.67+24.80 (+0.42%)
COMP18,518.61+102.32 (+0.56%)
TNX4.18%-0.04 (-0.95%)
CL$71.25-0.82 (-1.14%)
GC$2,674.30+14.60 (+0.55%)
DJIA43,842.10+168.45 (+0.39%)
SPX5,864.67+24.80 (+0.42%)
COMP18,518.61+102.32 (+0.56%)
TNX4.18%-0.04 (-0.95%)
CL$71.25-0.82 (-1.14%)
GC$2,674.30+14.60 (+0.55%)
HomePoliticsDrugs are widely used to sedate dementia patients. Her sons wanted to keep her off them
Home/Politics
Politics•NPR NATIONAL NEWS EXCLUSIVE

Drugs are widely used to sedate dementia patients. Her sons wanted to keep her off them

KEY POINTS

  • •Potent sedating medications are often used on agitated people with dementia in long-term care facilities despite federal efforts to discourage them. A clash over whether to drug a Michigan woman illuminates the wrenching decisions families and guardians face.
  • •Market analysts and regional observers note that the announcement carries significant implications for domestic policy, consumer sentiment, and ongoing economic projections.
  • •Additional reporting and official statements will be incorporated as further briefings are scheduled from the NPR National News newsroom.
NPR National News Wire
NPR National News Wire(National Correspondent)

PUBLISHED SAT, SEP 5 2026•(2h ago)

Drugs are widely used to sedate dementia patients. Her sons wanted to keep her off them
Drugs are widely used to sedate dementia patients. Her sons ... Reported by NPR National News.US Hot News Wire

Potent sedating medications are often used on agitated people with dementia in long-term care facilities despite federal efforts to discourage them. A clash over whether to drug a Michigan woman illuminates the wrenching decisions families and guardians face.

Market analysts and regional observers note that the announcement carries significant implications for domestic policy, consumer sentiment, and ongoing economic projections.

“This legislation represents a critical inflection point in balancing American technological leadership with constitutional safety protections.”

— Congressional Commerce Committee Briefing

Additional reporting and official statements will be incorporated as further briefings are scheduled from the NPR National News newsroom.

Editorial Verification & Disclosure

Reporting contributed by the Washington D.C. and New York bureaus. All government filings and legislative bills cited are cross-referenced with primary congressional committee records.

Filed Under:#Politics#NPRNationalNews#USNews

Reader Reactions to this Reporting

Related Reports & Further Wire Coverage

Browse All Desks →
Sam Altman says OpenAI won’t go public until its models are safe
TechnologySam Altman says OpenAI won’t go public until its models are safe

For months, people have wondered when OpenAI will go public. CEO Sam Altman says it won't happen until the company can make better promises about model safety, with no firm timeline in sight. "We intend to continue with AI progress … but as the models have had this surge forward in capability, and we see […]

10h agoRead Story
What's behind HHS claims that gender-affirming care 'may' radicalize
TechnologyWhat's behind HHS claims that gender-affirming care 'may' radicalize

The report is the agency's latest effort to chip away at trust in established health care models for transgender people. Critics say it frames transgender identity as illegitimate or even dangerous.

A startup wants to build a massive nuclear-powered data center on public land in Utah
TechnologyA startup wants to build a massive nuclear-powered data center on public land in Utah

Valar Atomics wants to place over 450 reactors on more than 9,500 acres in Utah to power a huge data center project.

The Morning Wire Briefing

Start Your Morning Informed, Not Overwhelmed.

Get our curated nonpartisan 5-minute rundown of Capitol Hill votes, Wall Street movers, and breaking national developments delivered straight to your inbox at 6:00 AM EST.

Zero spam. Nonpartisan reporting. Unsubscribe anytime with 1-click.